Dr. Kathleen Jacobs Regulatory Affairs Director Kathleen has a background in Biotechnology and holds a PhD in Animal Sciences. She has spent over 20 years in the food and pharmaceutical sectors, before joining Rousselot’s Regulatory Affairs team in 2020. Which aspect of your work inspires you the mo

Dr. Jeff Daelman Business Development Manager, Innovations Jeff has a bioengineering background and holds a PhD in Applied Biological Sciences. He spent several years working on parenteral process validation at Pfizer, before joining Rousselot’s product and business development team in 2016. What’s

Jeroen Geeraerts Business Development Manager Jeroen graduated as a Pharmacist in Drug Development and holds a Master’s in General Management. He has spent several years in both technical and commercial roles across the pharmaceutical and medical device industry, before joining Rousselot’s Business

Recent research conducted jointly by the University of Twente and Rousselot has highlighted a crucial, often overlooked factor in improving the reliability of 3D in vitro tumor models: the presence of endotoxins. These large, immunogenic molecules, commonly found in the environment, can significantl

Global expertise, local teams We are skilled in converting our global expertise into solutions that match specific local market requirements. Throughout our organization, we focus on working closely with our customers at every level with a comprehensive, highly developed range of services designed t

Biomedical applications of gelatin Over the past few decades, gelatin has been used for an increasing number of biomedical applications , from the lab bench to the clinic. Gelatins and collagens are highly biocompatible, biodegradable and tunable, making them useful scaffolds , substrates and excipi

Our mission: enabling food, pharma and tech to meet global demands Rousselot® Functional Ingredients is one of three strategic segments within Rousselot, the world’s leading brand for collagen-based solutions*. Our mission at Rousselot Functional Ingredients is to serve food, pharmaceutical and tech

If you haven’t booked to meet us already, then get in touch with us directly here Contact us Our GelMA expert Dr. Jeff Daelman will share how Rousselot Biomedical re-engineered the gelatin modification process and will talk about process , consistency , purity , and safety , in his Company Presentat

Advances in 3D Bioprinting conference enhances a new advanced technology that can produce complex tissues with precise and individualized designs. It has the potential to significantly impact regenerative medicine , disease modeling, drug discovery, and food engineering with rapidly evolving bioprin